The Challenges of Living With an Implantable Cardioverter Defibrillator: A Qualitative Study

Mohammad Abbasi, Reza Negarandeh, Reza Norouzadeh, Amir Reza Shojae Mogadam, Mohammad Abbasi, Reza Negarandeh, Reza Norouzadeh, Amir Reza Shojae Mogadam

Abstract

Background: Dysrhythmia is one of the most common causes of sudden cardiac death worldwide. An implantable cardioverter defibrillator is the most effective method of treatment for dysrhythmias causing cardiac arrest. However, living with an implantable cardioverter defibrillator is associated with challenges such as fear, anxiety, and depression.

Objectives: The purpose of this study was to identify the challenges of living with an implantable cardioverter defibrillator.

Patients and methods: In this qualitative study, an interpretive phenomenological approach was used, with thirteen participants (seven men and six women) between the ages of 21 and 70 years old (mean = 58.15, SD = 14.4). The duration of having an implantable cardioverter defibrillator was 1 - 120 months (mean = 23.15, SD = 33.31). Maximum variation sampling was used to purposefully select the participants from the governmental Imam Khomeini hospital in Tehran, Iran, between May and October of 2013. Semi-structured interviews were conducted for 30 to 45 minutes, and Van Manen's six-step method was used in this study.

Results: The challenges of living with an implantable cardioverter defibrillator include: living with fear, concerns about the future, concerns about device malfunction, fearing death during the shock, pain due to the shock, loss of control, the cost of the device, and the lifestyle limitations.

Conclusions: Patients who live with implantable cardioverter defibrillators face many concerns and challenges. Therefore, the role of nurses in teaching patients before and after implementation is very important.

Keywords: Challenge; Implantable Cardioverter Defibrillator; Phenomenology.

References

    1. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA. 2007;298(4):405–12. doi: 10.1001/jama.298.4.405.
    1. Josephson M, Wellens HJ. Implantable defibrillators and sudden cardiac death. Circulation. 2004;109(22):2685–91. doi: 10.1161/01.CIR.0000129322.97266.F3.
    1. Ketilsdottir A, Albertsdottir HR, Akadottir SH, Gunnarsdottir TJ, Jonsdottir H. The experience of sudden cardiac arrest: becoming reawakened to life. Eur J Cardiovasc Nurs. 2014;13(5):429–35. doi: 10.1177/1474515113504864.
    1. Lauck SB. Change in patient-reported outcomes after cardioverter-defibrillator implantation. Canada: university of British clumbia; 2013.
    1. Fluur C, Bolse K, Stromberg A, Thylen I. Patients' experiences of the implantable cardioverter defibrillator (ICD); with a focus on battery replacement and end-of-life issues. Heart Lung. 2013;42(3):202–7. doi: 10.1016/j.hrtlng.2012.11.006.
    1. Belardinelli R, Capestro F, Misiani A, Scipione P, Georgiou D. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy. Eur J Cardiovasc Prev Rehabil. 2006;13(5):818–25. doi: 10.1097/01.hjr.0000230104.93771.7d.
    1. Watkins LJ, Mirowski M, Mower MM, Reid PR, Freund P, Thomas A, et al. Implantation of the automatic defibrillator: the subxiphoid approach. Ann Thorac Surg. 1982;34(5):515–20.
    1. Haghjoo M, Mollazadeh R, Aslani A, Dastmalchi J, Mashreghi-Moghadam H, Heidari-Mokarar H, et al. Prediction of midterm performance of active-fixation leads using current of injury. Pacing Clin Electrophysiol. 2014;37(2):231–6. doi: 10.1111/pace.12262.
    1. Dunbar SB, Langberg JJ, Reilly CM, Viswanathan B, McCarty F, Culler SD, et al. Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients. Pacing Clin Electrophysiol. 2009;32(10):1259–71. doi: 10.1111/j.1540-8159.2009.02495.x.
    1. Conelius J. A woman's experience: living with an implantable cardioverter defibrillator. Appl Nurs Res. 2015;28(2):192–6. doi: 10.1016/j.apnr.2014.11.002.
    1. Ansari S, Arbabi M. Cognitive behavioral therapy (CBT) in a Patient with Implantable Cardioverter Defibrillator (ICD) and Posttraumatic stress disorder (PTSD). Iran j psychiatry. 2014;9(3):181.
    1. Kajanova A, Bulava A, Eisenberger M. Factors influencing psychological status and quality of life in patients with implantable cardioverter-defibrillators. Neuro Endocrinol Lett. 2014;35 Suppl 1:54–8.
    1. Dunbar SB. Psychosocial issues of patients with implantable cardioverter defibrillators. Am J Crit Care. 2005;14(4):294–303.
    1. Bostwick JM, Sola CL. An updated review of implantable cardioverter/defibrillators, induced anxiety, and quality of life. Psychiatr Clin North Am. 2007;30(4):677–88. doi: 10.1016/j.psc.2007.07.002.
    1. Kikkenborg Berg S, Stoier L, Moons P, Zwisler AD, Winkel P, Ulrich Pedersen P. Emotions and health: findings from a randomized clinical trial on psychoeducational nursing to patients with implantable cardioverter defibrillator. J Cardiovasc Nurs. 2015;30(3):197–204. doi: 10.1097/JCN.0000000000000132.
    1. Holloway I. Qualitative research in nursing and healthcare. US: Wiley; 2009.
    1. van Manen M. Phenomenology of Practice, Phenomenology and Practice. Vol. 1. Alberta: University of Alberta; 2007. p. 11 – 30.
    1. Speziale HS, Streubert HJ, Carpenter DR. Qualitative research in nursing: Advancing the humanistic imperative. USA: Lippincott Williams & Wilkins; 2011.
    1. Pedersen SS, Sears SF, Burg MM, Van Den Broek KC. Does ICD indication affect quality of life and levels of distress? Pacing Clin Electrophysiol. 2009;32(2):153–6. doi: 10.1111/j.1540-8159.2008.02196.x.
    1. Flemme I, Johansson I, Stromberg A. Living with life-saving technology - coping strategies in implantable cardioverter defibrillators recipients. J Clin Nurs. 2012;21(3-4):311–21. doi: 10.1111/j.1365-2702.2011.03847.x.
    1. Freedenberg V, Thomas SA, Friedmann E. Anxiety and depression in implanted cardioverter-defibrillator recipients and heart failure: a review. Heart Fail Clin. 2011;7(1):59–68. doi: 10.1016/j.hfc.2010.08.008.
    1. Rahman B, Macciocca I, Sahhar M, Kamberi S, Connell V, Duncan RE. Adolescents with implantable cardioverter defibrillators: a patient and parent perspective. Pacing Clin Electrophysiol. 2012;35(1):62–72. doi: 10.1111/j.1540-8159.2011.03229.x.
    1. Wojcicka M, Lewandowski M, Smolis-Bak E, Szwed H. Psychological and clinical problems in young adults with implantable cardioverter-defibrillators. Kardiol Pol. 2008;66(10):1050–8. discussion 1059-60.
    1. Morken IM, Bru E, Norekval TM, Larsen AI, Idsoe T, Karlsen B. Perceived support from healthcare professionals, shock anxiety and post-traumatic stress in implantable cardioverter defibrillator recipients. J Clin Nurs. 2014;23(3-4):450–60. doi: 10.1111/jocn.12200.
    1. McDonough A. The experiences and concerns of young adults (18-40 years) living with an implanted cardioverter defibrillator (ICD). Eur J Cardiovasc Nurs. 2009;8(4):274–80. doi: 10.1016/j.ejcnurse.2009.03.002.
    1. Hayward RM, Dewland TA, Moyers B, Vittinghoff E, Tanel RE, Marcus GM, et al. Device complications in adult congenital heart disease. Heart Rhythm. 2015;12(2):338–44. doi: 10.1016/j.hrthm.2014.10.038.
    1. Zayac S, Finch N. Recipients' of implanted cardioverter-defibrillators actual and perceived adaptation: a review of the literature. J Am Acad Nurse Pract. 2009;21(10):549–56. doi: 10.1111/j.1745-7599.2009.00445.x.
    1. Palacios-Cena D, Losa-Iglesias ME, Alvarez-Lopez C, Cachon-Perez M, Reyes RA, Salvadores-Fuentes P, et al. Patients, intimate partners and family experiences of implantable cardioverter defibrillators: qualitative systematic review. J Adv Nurs. 2011;67(12):2537–50. doi: 10.1111/j.1365-2648.2011.05694.x.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel